Caplin Point Laboratories’ injectables facility completes INVIMA audit successfully
This is also an important milestone in our product strategy for our expansion into the larger Latin American market
This is also an important milestone in our product strategy for our expansion into the larger Latin American market
The plant can reach an annual capacity of 300 crore tablets and 90 crore capsules
The inspection concluded with one minor observation in Form 483
Updated results from the EMBER-3 study showed that the drug -- Inluriyo (imlunestrant) -- as a standalone treatment cut the risk of progression or death by 38%
The innovation -- UPM Circular Renewable Black -- is the world’s first bio-based, near-infrared (NIR) detectable, carbon-negative black
These building blocks are essential to modern therapeutics, including fast-growing GLP-1 treatments for weight loss and diabetes
The company had achieved the highest "A" rating in Climate Change
The company will respond to the US FDA within the stipulated timelines
Subscribe To Our Newsletter & Stay Updated